Response to neoadjuvant chemotherapy leads to better survival outcomes in upper tract urothelial carcinoma.
Yu A, Hensley PJ, Huelster HL, Martin A, Potrezke A, Pham J, Raman JD, Pallauf M, Singla N, Katims A, Coleman J, Margulis V, Matin SF, Spiess PE.
Yu A, et al. Among authors: martin a.
BJU Int. 2025 Jan 18. doi: 10.1111/bju.16655. Online ahead of print.
BJU Int. 2025.
PMID: 39825642